1054
W. J. Pelaꢀez et al. / Tetrahedron 64 (2008) 1049–1057
Fvp reactions were carried out in a Vycor glass reactor, using
a tube furnace with a temperature-controller device. Oxy-
gen-free dry nitrogen was used as carrier gas. Approximately
40 mg samples were pyrolyzed. Contact times were around
10ꢂ2 s and a pressure ofw0.02 Torr was used. Products were
trapped at liquid air temperature, extracted with solvent
(CDCl3) and subjected to different analyses or separation
techniques. In all fvp experiments, the recovery of material
was >90%.
175.2. IR (KBr) cmꢂ1: 3318, 1743, 1656, 1556. Anal. Calcd
for C15H18N2O3 (274.32): C, 65.68; H, 6.61; N, 10.21.
Found: C, 65.30; H, 6.42; N, 9.83.
Compound 8f: yield 92%. Mp: 167–169 ꢁC. 1H NMR
(CDCl3) d (ppm): 1.83–1.96 (1H, m), 2.15–2.26 (1H, m),
2.51–2.73 (2H, m), 2.91 (1H, dd, J¼14.2, 7.5 Hz), 3.69
(3H, s), 4.80–4.94 (1H, m), 5.58 (1H, d, J¼10.6 Hz), 5.66
(1H, d, J¼10.6 Hz), 6.11–6.19 (1H, m), 7.20 (2H, d,
J¼7.0 Hz), 7.29 (1H, t, J¼7.4 Hz), 7.45 (2H, t, J¼7.8 Hz),
7.92 (1H, br s). 13C NMR (CDCl3) d (ppm): 26.6, 30.9,
44.0, 52.2, 52.8, 124.6, 125.6, 125.9, 127.9, 130.8, 136.7,
156.3, 173.1. IR (KBr) cmꢂ1: 3327, 1741, 1653, 1551.
Anal. Calcd for C15H18N2O2S (290.38): C, 62.04; H, 6.25;
N, 9.65. Found: C, 62.43; H, 6.62; N, 9.28.
Compounds 3–7 and 8a were prepared according to the
previously described methodology.9–12
4.2. General procedure for the preparation of thiourea
(8b–d,f) and urea (8e,g) derivatives
The appropriate aryl isothiocyanate or phenyl isocyanate
(10 mmol) was added to 4 (1.47 g, 9.5 mmol) dissolved in
30 mL of dry toluene, and the mixture was stirred at room
temperature for 1 h. The solution was then evaporated and
the product obtained was recrystallized from ethyl acetate/
n-hexane.
Compound 8g: yield: 81%. Mp: 151–153 ꢁC. 1H NMR
(CDCl3) d (ppm): 1.99 (1H, m), 2.33 (1H, d, J¼18.1 Hz),
2.48–2.58 (2H, m), 2.72 (1H, m), 3.70 (3H, s), 4.18 (1H,
m), 5.45 (1H, br), 5.64 (2H, coalesced signals), 7.09 (1H,
m), 7.2–7.33 (4H, m), 7.46 (1H, br). 13C NMR (CDCl3)
d (ppm): 28.0, 32.4, 45.9, 48.1, 52.7, 121.1, 124.0, 125.2,
125.5, 129.7, 139.5, 156.4, 175.5. IR (KBr) cmꢂ1: 3279,
3036, 1730, 1640. Anal. Calcd for C15H18N2O3 (274.32):
C, 65.68; H, 6.61; N, 10.21. Found: C, 65.28; H, 6.20;
N, 9.82.
Compound 8b: yield 77%. Mp: 102–105 ꢁC. 1H NMR
(CDCl3) d (ppm): 2.14–2.20 (1H, m), 2.45–2.58 (3H, m),
3.03 (1H, s), 3.66 (3H, s), 4.96 (1H, s), 5.60–5.68 (2H, m),
7.14 (2H, br d, J¼6.0 Hz), 7.25 (2H, br d, J¼6.0 Hz), 7.36
(1H, br m), 7.76 (1H, br s). 13C NMR (CDCl3) d (ppm):
27.0, 28.4, 42.2, 51.9, 52.8, 123.2, 125.2, 125.5, 125.6,
4.3. Cyclic compounds 1a–e
127.6, 131.7, 134.7, 137.9, 174.2, 182.8. IR (KBr) cmꢂ1
:
The appropriate thioureas (8a–d) or urea (8e) (5 mmol) were
refluxed in 30 mL of 25% HCl solution for 30 min. After
cooling, the crystalline products (1a–d) were separated by
vacuum filtration, washed with water and dried. Compound
1e was obtained after extraction with CHCl3 (3ꢄ50 mL),
drying (Na2SO4) and evaporation. The solid obtained was
purified by column chromatography on silica gel with a
mixture of toluene/EtOH (9:1) as eluent.
3331, 3162, 1702, 1597, 1531. Anal. Calcd for
C15H17ClN2O2S (324.83): C, 55.46; H, 5.28; N, 8.62. Found:
C, 55.09; H, 4.89; N, 8.24.
Compound 8c: yield 70%. Mp: 121–124 ꢁC. 1H NMR
(CDCl3) d (ppm): 2.12–2.21 (1H, m), 2.37–2.54 (3H, m),
2.42 (3H, s), 3.02 (1H, s), 3.61 (3H, s), 4.96 (1H, s), 5.61
(2H, m), 6.93 (1H, br s), 7.09 (2H, d, J¼8.1 Hz), 7.23
(2H, d, J¼8.1 Hz), 7.55 (1H, br s). 13C NMR (CDCl3)
d (ppm): 21.5, 27.0, 29.6, 41.9, 51.6, 52.3, 125.3, 125.4,
131.0, 132.2, 137.4, 173.8, 180.4. IR (KBr) cmꢂ1: 3332,
3153, 1707, 1526, 1242. Anal. Calcd for C16H20N2O2S
(304.41): C, 63.13; H, 6.62; N, 9.20. Found: C, 62.79; H,
6.22; N, 8.84.
Compound 1a: this compound was obtained as a white
crystalline product, yield: 85%. Mp: 241–244 ꢁC (lit.:10
243–245 ꢁC). The spectral data and physical properties
matched those reported previously.
Compound 1b: yield 81%. Mp: 208–212 ꢁC. 1H NMR
(DMSO-d6) d (ppm): 2.32 (3H, br s), 2.54 (1H, br s), 3.25
(1H, m), 3.93 (1H, m), 5.60 (1H, d, J¼10.1 Hz), 5.70 (1H,
d, J¼10.6 Hz), 7.13 (1H, br s), 7.30 (1H, br s), 7.42 (2H,
m), 10.22 (1H, br s). 13C NMR (DMSO-d6) d (ppm): 22.5,
26.6, 37.6, 46.3, 123.2, 124.7, 127.8, 129.8, 132.4, 140.7,
169.3, 180.0. IR (KBr) cmꢂ1: 3164, 1733, 1541, 1181.
Anal. Calcd for C14H13ClN2OS (292.78): C, 57.43; H,
4.48; N, 9.57. Found: C, 57.80; H, 4.85; N, 9.95.
Compound 8d: yield 84%. Mp: 137–139 ꢁC. 1H NMR
(CDCl3) d (ppm): 2.12–2.19 (1H, m), 2.36–2.57 (3H, m),
3.04 (1H, s), 3.63 (3H, s), 3.82 (3H, s), 4.98 (1H, s), 5.62
(2H, m), 6.76 (1H, s), 6.81 (1H, dd, J¼8.3, 16.4 Hz), 7.15
(1H, br s), 7.33 (1H, t, J¼8.1 Hz), 7.70 (1H, br s). 13C
NMR (CDCl3) d (ppm): 27.3, 29.8, 42.2, 52.0, 52.6, 56.1,
110.7, 113.6, 117.2, 125.6, 131.5, 132.0, 137.5, 160.6,
174.1. IR (KBr) cmꢂ1: 3374, 3172, 1736, 1530. Anal. Calcd
for C16H20N2O3S (320.41): C, 59.98; H, 6.29; N, 8.74.
Found: C, 60.36; H, 6.65; N, 9.18.
Compound 1c: yield 93%. Mp: 243–243 ꢁC. 1H NMR
(DMSO-d6) d (ppm): 2.27–2.32 (3H, m), 2.32 (3H, s),
3.17–3.39 (2H, m), 3.90 (1H, m), 5.60 (1H, d, J¼10.1 Hz),
5.67 (1H, d, J¼10.1 Hz, 6.97 (2H, d, J¼7.0 Hz), 7.17 (2H,
d, J¼8.1 Hz), 10.1 (1H, br s). 13C NMR (DMSO-d6)
d (ppm): 20.7, 22.7, 26.7, 37.7, 46.2, 123.2, 124.9, 128.9,
129.3, 136.8, 136.9, 169.4, 180.6. IR (KBr) cmꢂ1: 3163,
3023, 1730, 1541, 1234. Anal. Calcd for C15H16N2OS
(272.37): C, 66.15; H, 5.92; N, 10.29. Found: C, 66.52; H,
6.29; N, 10.65.
Compound 8e: yield 65%. Mp: 109–111 ꢁC. 1H NMR
(CDCl3) d (ppm): 2.16–2.27 (1H, m), 2.31–2.44 (2H, m),
2.46–2.56 (1H, m), 2.84–2.91 (1H, m), 3.67 (3H, s), 4.39–
4.48 (1H, m), 5.63 (2H, dd, J¼10.3, 19.1 Hz), 5.74–5.76
(1H, m), 7.04 (1H, t, J¼6.6 Hz), 7.12 (1H, br s), 7.22–7.32
(4H, m). 13C NMR (CDCl3) d (ppm): 26.4, 31.5, 42.9,
46.5, 52.6, 121.3, 124.1, 125.6, 125.7, 129.8, 139.5, 156.2,